Invitational Awards

CURRENT INVITATIONAL FUNDS

Please note, only a limited number of applications will be accepted from each department (or division within the DOM) for each funding opportunity. Please seek approval with your department chair or division chief prior to submitting your application

V Scholar Award
V Foundation
Amount: $200,000 over two years
Internal Deadline: March 9, 2020
Indirect Cost: 0% from foundation. The BRI will provide funds to successful applicants to meet the Partners 15% IDC minimum
BWH nominations: 1
Internal Submission Portal: http://bwhcfdd.partners.org/Listing.aspx?courseId=499

Summary: This award supports a range of projects from laboratory-based fundamental research through bench-to-bedside research for any area of ADULT cancer by early tenure-track faculty. Applicants must have been appointed to their first full-time Assistant Professor position within the last 5 years, and NOT yet been promoted to Associate Professor, already hold an R01 (or equivalent) or be a co-leader on projects such as SPORE or NIH grant mechanisms like U01, DP1, DP2, R37, and R23.

 

 

Exceptional Project Grant
Breast Cancer Alliance
Amount: $100,000 for one year
Internal Deadline: March 9, 2020
Indirect Costs: 8% from the foundation. The BRI will provide funds to successful applicants to meet the Partners 15% IDC minimum
BWH nominations: 2
Internal Submission Portal: http://bwhcfdd.partners.org/Listing.aspx?courseId=497

Summary: Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research.

 

Translational Cancer Research Grant Program 

V Foundation

Amount: $600,000 over 3 years

Internal BWH Deadline: April 1, 2020

Indirect Overhead Rate: 10% from the foundation, BWH will provide funds to meet the 15% IDC minimum.

# of BWH nominations: One. To be nominated, you must submit an internal application here: http://bwhcfdd.partners.org/Listing.aspx?courseId=503. Only one application from each BWH department (and ONE application from each division within the Department of Medicine) may be submitted for this limited submission, invitational funding opportunity. Please seek approval from you department chair or division chief before submitting your application.

 

Summary: Supports translational research projects within the scope of adult cancer research. Projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms.

 

Pew Biomedical Scholars

Pew Charitable Trusts

Amount: $300,000 over four years

Deadline: nomination due April 13, 2020

Indirect Overhead Rate: 8%, BRI will cover difference to 15%

Internal Application Portal: http://bwhcfdd.partners.org/Listing.aspx?courseId=500

 

Summary: Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. Strong proposals will incorporate particularly creative and pioneering approaches. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research.

 

Pathways to Stop Diabetes

American Diabetes Association

Amount: Up to $1,625,000 over 5-7 years

Internal BWH Deadline: June 1, 2020

Indirect Overhead Rate: Between 10% and 30% – see funding details below. When necessary, BWH will cover the difference to meet the 15% IDC minimum.

# of BWH nominations: One. To be nominated, you must submit an internal application here: http://bwhcfdd.partners.org/Listing.aspx?courseId=502. Only one application to one ADA Pathway Award will be accepted from each BWH department (or division within the Department of Medicine) to be considered for the BWH nominee. Please seek approval from your department chair or division chief before submitting your application.

 

Description: Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication.

Initiator Award: Supports the transition of scientists from mentored training to independent research faculty.

Accelerator Award: Available to early-career diabetes investigators (who have not yet received a second R01) proposing innovative and ambitious diabetes-related research programs.

Visionary Award: Highly competitive award intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.

 

 

Young Investigator Grant
Breast Cancer Alliance
Amount: $125,000 over two years
Internal Deadline: June 8, 2020
Indirect Costs: 8% from the foundation. The BRI will provide funds to successful applicants to meet the Partners 15% IDC minimum
BWH nominations: 2
Internal Submission Portal: http://bwhcfdd.partners.org/Listing.aspx?courseId=498

Summary: Clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers, are encouraged to apply. Applicants must (i) have held a faculty position for no more than four years following the completion of their training, as of February 1, 2021; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support. For clarity, current postdoctoral fellows who do not yet hold a faculty position are eligible to apply, provided they meet all the other stated criteria for Young Investigators.

X